Cerebrospinal fluid levels of alpha-synuclein measured using a poly-glutamic acid-modified gold nanoparticle-doped disposable neuro-biosensor system

Basit Öğe Kaydı
dc.contributor.authorKaraboga, Munteha Nur Sonuc
dc.contributor.authorSezgintürk, Mustafa Kemal
dc.date.accessioned2025-01-27T20:27:22Z
dc.date.available2025-01-27T20:27:22Z
dc.date.issued2019
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractAlpha-synuclein (SYN) is a prominent key protein in Parkinson-type dementia. Measurement of the amount of this protein found in the cerebrospinal fluid (CSF) using precise techniques may help in the diagnosis and prognosis of the disease. In this study, a gold nanoparticle (AuNP)-polyglutamic acid (PGA)-modified indium tin oxide (ITO)-based disposable neuro-biosensor system was designed for alpha-synuclein (alpha-SYN), an important biomarker of Parkinson's disease. Glutamic acid was formed by electropolymerization on the electrode surface. The parameters that can affect the performance of the biosensing probe were optimized. The techniques used in the design of the immobilization steps, the optimization studies, and the evaluation of the analytical performance of the targeted neuro-biosensor are electrochemical impedance spectroscopy (EIS), cyclic voltammetry (CV) and square wave voltammetry (SWV). Charge transfer resistance (Rct) changes were highly linear and sensitive with the alpha-SYN concentration in the 4-2000 pg mL(-1) range and associated with a limit of detection of 0.135 pg mL(-1). With the designed disposable neuro-biosensor system, the amount of alpha-SYN found in CSF samples was determined by the standard addition technique and found to be strikingly sensitive to the target analyte. Morphological and chemical changes on the sensing surface were evaluated by scanning electron microscopy (SEM) and Fourier transform infrared spectroscopy (FTIR). In addition, it was determined that the PGA-modified, AuNP-doped neuro-biosensor system has great reproducibility potency, long storage stability, and regeneration capacity. We suggest that the AuNP-PGA combination platform is ideal for use as a biosensing probe to detect alpha-SYN.
dc.identifier.doi10.1039/c8an01279b
dc.identifier.endpage621
dc.identifier.issn0003-2654
dc.identifier.issn1364-5528
dc.identifier.issue2
dc.identifier.pmid30457584
dc.identifier.scopus2-s2.0-85059884585
dc.identifier.scopusqualityQ1
dc.identifier.startpage611
dc.identifier.urihttps://doi.org/10.1039/c8an01279b
dc.identifier.urihttps://hdl.handle.net/20.500.12428/22671
dc.identifier.volume144
dc.identifier.wosWOS:000457297600027
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherRoyal Soc Chemistry
dc.relation.ispartofAnalyst
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectElectrochemical Immunosensor
dc.subjectDirect Electrodeposition
dc.subjectBiomarkers
dc.subjectDisease
dc.subjectSurface
dc.subjectVoltammetry
dc.subjectDiagnosis
dc.subjectFuture
dc.titleCerebrospinal fluid levels of alpha-synuclein measured using a poly-glutamic acid-modified gold nanoparticle-doped disposable neuro-biosensor system
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu